Calreticulin mutation does not modify the IPSET score for predicting the risk of thrombosis among 1150 patients with essential thrombocythemia

Blood. 2014 Oct 16;124(16):2611-2. doi: 10.1182/blood-2014-08-596676.

¹ Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
² Research Foundation, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
³ Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
⁴ Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
⁵ Division of Hematology, Department of Medicine, Ospedale di Circolo e Fondazione Macchi, Varese, Italy.

No abstract available

Publication types